<DOC>
	<DOCNO>NCT01729468</DOCNO>
	<brief_summary>The objective study test efficacy low-dose aspirin ( 160 mg/day ) , give bedtime start early pregnancy ( ≤ 15 +6 week gestation ) nulliparous pregnant woman select `` high-risk '' presence bilateral uterine artery notch and/or bilateral uterine artery PI ≥ 1.7 first trimester ultrasound scan ( 11-13+6 week ) , prevent occurrence pre-eclampsia small gestational age birth .</brief_summary>
	<brief_title>Prevention Pre-eclampsia SGA Low-Dose Aspirin Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers</brief_title>
	<detailed_description />
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Eclampsia</mesh_term>
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Age ≥ 18 year Nulliparous ( previous pregnancy ≥ 22 SA ) Singleton pregnancy Gestational age ≤ 15 +6 week Bilateral uterine artery notch ( grade ≥ 2 ) and/or bilateral uterine artery PI ≥ 1.7 first trimester ultrasound ( CRL 45 84 mm ) Maternal informed consent obtain Affiliated social security system Women consider voluntary pregnancy termination ( ≤ 14 week ) Preexisting ( maternal ) indication premature delivery 37 week Fetal condition detect first trimester scan ( fetal malformation nuchal translucency ≥ 95th percentile ) Women anticoagulation Allergy hypersensitivity Kardegic® one constituent Secondary hemostasis disorder responsible bleeding risk bleed Peptic ulcer evolution Lupus antiphospholipid syndrome</criteria>
	<gender>Female</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Low Dose Acetylsalicylic Acid</keyword>
	<keyword>Prevention</keyword>
	<keyword>Pre-eclampsia</keyword>
	<keyword>Intra-uterine Growth Restriction</keyword>
	<keyword>Primiparous Women</keyword>
	<keyword>Bilateral Uterine Artery Notches</keyword>
	<keyword>First Quarter</keyword>
</DOC>